• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012464-12
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Stenosis (2263); Test Result (2695)
Event Date 05/23/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The 3.5 x 28 absorb bioresorbable vascular scaffold (bvs) referenced in describe event or problem and concomitant medical products is filed under a separate medwatch report number.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the us.
 
Event Description
It was reported that on (b)(6) 2015, a 3.5 x 28 mm and a 3.5 x 12 mm absorb bioresorbable vascular scaffolds (bvs) were successfully implanted in the mid right coronary artery (rca) lesion.On (b)(6) 2017, the patient was hospitalized for unstable angina and a positive stress test.Coronary imaging was performed and diffuse mid rca restenosis was noted.Another percutaneous intervention was performed, placing an unspecified drug eluting stent (des) in the mid rca as treatment.The event resolved on (b)(6) 2017.There was no additional information provided.
 
Manufacturer Narrative
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.It should be noted that the reported patient effects of angina and restenosis, as listed in the absorb bioresorbable scaffold system instructions for use (ifu), are known adverse events associated with the use of a coronary scaffold in native coronary arteries.A conclusive cause for the reported patient effects and the relationship to the product, if any, cannot be determined; however, the reported treatments appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event Description
Subsequent to the previously filed medwatch report, additional information was received: on (b)(6) 2017, the patient complained of dyspnea on exertion and chest heaviness.Restenosis was noted in both the 3.5x28mm and a 3.5x12mm absorb bioresorbable vascular scaffolds and another stent was implanted as treatment.On (b)(6) 2017, the patient was discharged home.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6647060
MDR Text Key77760351
Report Number2024168-2017-05143
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 07/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/11/2015
Device Catalogue Number1012464-12
Device Lot Number4111261
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/06/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
3.5X28MM ABSORB BIORESORBABLE VASCULAR SCAFFOLD
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
Patient Weight66
-
-